Centrosome amplification and clonal evolution in multiple myeloma: Short review

Area of Science:

• Oncology
• Cell Biology
• Genetics

Background:

• Multiple myeloma (MM) is characterized by heterogeneous clones, each with distinct clinical behaviors.
• Previous research on centrosome amplification (CA) in MM has yielded conflicting results regarding its clinical implications.
• The role of CA in MM may differ from its function in other cancers.

Purpose of the Study:

• To discuss the presence and evolutionary dynamics of MM subclones exhibiting centrosome amplification (CA).
• To investigate the potential impact of CA-positive clones on MM progression and therapeutic strategies.
• To address the question of whether CA-positive clones represent aggressive evolutionary adaptations or markers of cellular damage leading to elimination.

Main Methods:

• This is a review article, synthesizing existing research on MM and centrosome amplification.
• Analysis of intraclonal heterogeneity within MM.
• Evaluation of the literature on the clinical significance of CA in MM.

Main Results:

• MM exhibits intraclonal heterogeneity, with the potential existence of subclones characterized by centrosome amplification (CA).
• The evolutionary trajectory of CA-positive clones under selective pressures remains an area of active investigation.
• Conflicting data exists regarding the clinical impact of CA in MM, necessitating further research.

Conclusions:

• The existence and behavior of MM subclones with CA require further elucidation.
• Understanding the role of CA in MM is crucial for determining its potential as a prognostic marker or therapeutic target.
• Further research is needed to clarify whether CA indicates aggressive clones or a mechanism for eliminating abnormal cells in MM.